# Methylprednisolone Acetate Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 23
- Latest FDA row update: 08/18/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Amneal Pharmaceuticals — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1) — FDA availability: Limited Availability — updated: 06/17/2026
- Amneal Pharmaceuticals — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5) — FDA availability: Available — updated: 06/17/2026
- Amneal Pharmaceuticals — Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1) — FDA availability: Available — updated: 06/17/2026
- Amneal Pharmaceuticals — Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5) — FDA availability: Available — updated: 06/17/2026
- Eugia US LLC — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01) — FDA availability: Unavailable — updated: 08/06/2026
- Eugia US LLC — Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01) — FDA availability: Unavailable — updated: 08/06/2026
- Par Health, USA LLC — Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01) — FDA availability: Unavailable — updated: 08/18/2026
- Pfizer Inc. — Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01) — FDA availability: Available — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02) — FDA availability: Available — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03) — FDA availability: Limited Availability — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51) — FDA availability: Available — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52) — FDA availability: Available — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01) — FDA availability: Limited Availability — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03) — FDA availability: Limited Availability — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22) — FDA availability: Unavailable — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23) — FDA availability: Limited Availability — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02) — FDA availability: Available — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12) — FDA availability: Available — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01) — FDA availability: Limited Availability — updated: 08/07/2026
- Pfizer Inc. — Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03) — FDA availability: Available — updated: 08/07/2026
- Sagent Pharmaceuticals — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05) — FDA availability: Unavailable — updated: 08/18/2026
- Sagent Pharmaceuticals — Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10) — FDA availability: Unavailable — updated: 08/18/2026
- Sagent Pharmaceuticals — Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05) — FDA availability: Limited Availability — updated: 08/18/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/methylprednisolone-acetate-injection)
- [JSON record](https://citefacts.com/shortages/methylprednisolone-acetate-injection.json)